Valuation: CVRx, Inc.

Market Cap 15Cr 13Cr 12Cr 11Cr 20Cr 1.39TCr 21Cr 139.64Cr 55Cr 693.73Cr 55Cr 54Cr 2.29TCr P/E 2026 *
-2.8x
P/E 2027 * -2.9x
Enterprise Value 17Cr 15Cr 14Cr 13Cr 24Cr 1.63TCr 25Cr 164.04Cr 64Cr 814.99Cr 64Cr 63Cr 2.69TCr EV / Sales 2026 *
2.63x
EV / Sales 2027 * 2.81x
Free-Float
85.82%
Yield 2026 *
-
Yield 2027 * -
1 day+6.28%
1 week+12.70%
Current month+6.28%
1 month-1.79%
3 months-30.99%
6 months-20.98%
Current year-22.54%
1 week 4.86
Extreme 4.86
5.59
1 month 4.64
Extreme 4.64
5.93
Current year 4.37
Extreme 4.3701
9.84
1 year 4.37
Extreme 4.3701
11.3
3 years 4.3
Extreme 4.2993
33.14
5 years 4.3
Extreme 4.2993
33.14
10 years 4.3
Extreme 4.2993
33.14
Manager TitleAgeSince
Chief Executive Officer 60 12/02/2024
Director of Finance/CFO 43 01/10/2020
Chief Operating Officer 57 11/08/2025
Director TitleAgeSince
Director/Board Member 61 01/10/2008
Director/Board Member 57 01/07/2020
Director/Board Member 52 01/07/2020
Date Insider Type Main position Quantity % Market Cap.
27/02/26 Free

Chief Executive Officer

4,04,763 1.5443%
27/02/26 Free

Chief Operating Officer

38,000 0.1450%
27/02/26 Free

Executive/Senior Manager

90,964 0.3471%
Change 5-day change 1-year change 3-year change Capi.($)
+6.28%+12.70%-27.25%-69.60% 15Cr
+0.57%+1.10%+32.92%+26.54% 1.27TCr
+0.27%+2.30%+26.33%+23.35% 682.39Cr
+1.04%+0.73%+52.34%+26.93% 602.31Cr
+5.82%+8.09% - - 536.41Cr
-2.88%+5.86%-21.01%+40.05% 461.33Cr
+0.28%+4.30%-19.66%-17.76% 416.06Cr
-1.48%+2.75%-21.32%+196.77% 179.76Cr
+3.23%-10.04%+35.34%-47.35% 178.4Cr
+0.65%+0.49%+59.54%-4.33% 162.88Cr
Average +1.37%+2.39%+13.03%+19.40% 450.65Cr
Weighted average by Cap. +0.87%+2.37%+21.48%+25.75%

Financials

2026 *2027 *
Net sales 6.53Cr 5.67Cr 5.3Cr 4.86Cr 9.17Cr 622.26Cr 9.33Cr 62Cr 24Cr 310.31Cr 25Cr 24Cr 1.02TCr 7.62Cr 6.62Cr 6.18Cr 5.67Cr 11Cr 726.08Cr 11Cr 73Cr 29Cr 362.09Cr 29Cr 28Cr 1.19TCr
Net income -5.28Cr -4.59Cr -4.29Cr -3.93Cr -7.42Cr -503.46Cr -7.55Cr -51Cr -20Cr -251.07Cr -20Cr -19Cr -828.11Cr -5.21Cr -4.53Cr -4.23Cr -3.88Cr -7.32Cr -496.98Cr -7.45Cr -50Cr -20Cr -247.84Cr -20Cr -19Cr -817.46Cr
Net Debt 2.55Cr 2.22Cr 2.07Cr 1.9Cr 3.58Cr 243.17Cr 3.65Cr 24Cr 9.56Cr 121.27Cr 9.58Cr 9.37Cr 399.98Cr 6.84Cr 5.95Cr 5.55Cr 5.1Cr 9.61Cr 652.33Cr 9.78Cr 65Cr 26Cr 325.31Cr 26Cr 25Cr 1.07TCr
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
03/26/03 $5.500 +6.28% 1,28,811
31/26/31 $5.175 -3.81% 95,412
30/26/30 $5.380 +8.69% 2,68,691
29/26/29 $4.950 0.00% 1,53,855
28/26/28 $4.950 +1.43% 1,53,586
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
5.500USD
Average target price
11.17USD
Spread / Average Target
+103.03%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CVRX Stock